Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | FGFR3 |
Variant | Y375C |
Impact List | missense |
Protein Effect | gain of function |
Gene Variant Descriptions | FGFR3 Y375C (corresponds to Y373C in the canonical isoform) lies within the transmembrane domain of the Fgfr3 protein (UniProt.org). Y375C confers a gain of function to the Fgfr3 protein as demonstrated by ligand-independent constitutive phosphorylation in vitro and transformation of cells in culture (PMID: 19749790). |
Associated Drug Resistance | Y |
Category Variants Paths |
FGFR3 mutant FGFR3 act mut FGFR3 Y375C |
Transcript | NM_001163213.2 |
gDNA | chr4:g.1804372A>G |
cDNA | c.1124A>G |
Protein | p.Y375C |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_006713869 | chr4:g.1804372A>G | c.1124A>G | p.Y375C | RefSeq | GRCh38/hg38 |
XM_006713870.2 | chr4:g.1804372A>G | c.1124A>G | p.Y375C | RefSeq | GRCh38/hg38 |
XM_006713870.1 | chr4:g.1804372A>G | c.1124A>G | p.Y375C | RefSeq | GRCh38/hg38 |
XM_047449821.1 | chr4:g.1804372A>G | c.1124A>G | p.Y375C | RefSeq | GRCh38/hg38 |
XM_006713871.1 | chr4:g.1804372A>G | c.1124A>G | p.Y375C | RefSeq | GRCh38/hg38 |
XM_006713868.1 | chr4:g.1804372A>G | c.1124A>G | p.Y375C | RefSeq | GRCh38/hg38 |
NM_001163213.2 | chr4:g.1804372A>G | c.1124A>G | p.Y375C | RefSeq | GRCh38/hg38 |
XM_006713868 | chr4:g.1804372A>G | c.1124A>G | p.Y375C | RefSeq | GRCh38/hg38 |
NM_001163213 | chr4:g.1804372A>G | c.1124A>G | p.Y375C | RefSeq | GRCh38/hg38 |
XM_006713871.2 | chr4:g.1804372A>G | c.1124A>G | p.Y375C | RefSeq | GRCh38/hg38 |
XM_006713871 | chr4:g.1804372A>G | c.1124A>G | p.Y375C | RefSeq | GRCh38/hg38 |
XM_047449820.1 | chr4:g.1804372A>G | c.1124A>G | p.Y375C | RefSeq | GRCh38/hg38 |
NM_001163213.1 | chr4:g.1804372A>G | c.1124A>G | p.Y375C | RefSeq | GRCh38/hg38 |
XM_006713868.2 | chr4:g.1804372A>G | c.1124A>G | p.Y375C | RefSeq | GRCh38/hg38 |
XM_006713870 | chr4:g.1804372A>G | c.1124A>G | p.Y375C | RefSeq | GRCh38/hg38 |
XM_006713869.1 | chr4:g.1804372A>G | c.1124A>G | p.Y375C | RefSeq | GRCh38/hg38 |
XM_006713869.2 | chr4:g.1804372A>G | c.1124A>G | p.Y375C | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04972253 | Phase I | Infigratinib | Phase I BLASST-3 Trial ((BLASST)-3) | Withdrawn | 0 |